George K.
- Country
- Germany
- Department
- 1605:Endokrinologie & Stoffwechselerkranknugen
Research Overview
- Evaluation of Safety and Tolerability of Teprotumumab Dosing Durations in Patients with Thyroid Eye Disease: A Phase 3b/4 Randomized, Double-Masked, Multicenter Trial
- Phase 3 Randomized Quadruple-Masked Placebo-Controlled Trial of Batoclimab in Active Thyroid Eye Disease
- Evaluation of Batoclimab Efficacy and Safety in Patients with Graves' Disease: An Open-label, Proof-of-Concept Study
Data & Insights
Has run more than one trial at 29 of 134 partner sites.
Specializations
Thyroid Disorders
This clinical investigator specializes in the treatment of thyroid eye disease (TED) and related autoimmune thyroid conditions, with particular focus on innovative therapeutic approaches for managing ocular manifestations.
- Thyroid Eye Disease Management
- Autoimmune Thyroid Disorders
- Graves' Disease Treatment
The investigator's work encompasses comprehensive evaluation of novel therapeutic agents for thyroid-related eye conditions.
Ophthalmology
Focused on addressing ocular manifestations of thyroid disorders, particularly examining innovative treatments for proptosis and other eye-related complications.
- Proptosis Management
- Ocular Inflammation
- Vision Protection Strategies
The investigator evaluates emerging therapeutic approaches for preserving ocular function in thyroid-related disorders.
Immunology
Specializes in investigating autoimmune mechanisms underlying thyroid disorders, with emphasis on targeted immunological interventions and treatment protocols.
- Autoimmune Response Modulation
- Immunotherapy Applications
- Novel Biological Agents
The research focus includes evaluation of immunological treatments for thyroid-related conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.